New Delhi, Dec 12 (IANS) India is the most pro-vaccine country in the world with more than 98 per cent of the country's eligible population showing willingness to get inoculated against the deadly Coronavirus, as per the findings of the IANS-CVoter Covid Vaccine Tracker.
Mirroring the high acceptance levels of vaccination shown in CVoter Covid Vaccine Tracker, more than 89 lakh vaccines were administered in past 24 hours, as per the data released by Health Ministry. India's cumulative Covid-19 vaccination coverage (Dose 1+ Dose 2) has now exceeded 133 crore.
Of the 90 crore adult population of the country, more than 81 crore people have got their Dose 1 of the Covid-19 vaccine. According to the findings of the IANS-CVoter Covid Vaccine Tracker, of the remaining 9 crore unvaccinated, 7.5 crore want to their jab to get protection against the lethal virus.
Only 1.5 crore people have shown either unwillingness or hesitancy to get their jab.
The tracker also found that even those who had shown unwillingness or hesitancy to get vaccinated were not rigid against taking the jab. They had their reasons for not getting vaccine and a session or two of counselling by the health personnel may easily convince them to get vaccinated.
As per the vaccination data released by Health Ministry, India is administering around 60–70 lakh Covid-19 vaccine doses every day. With this speed of vaccination, India will be able to vaccinate whole of its adult population with first dose by the end of this month.
In the vaccination drive, the entire population may not be counted, as the eligible population is only above 18 years. Compared to India, vaccine hesitancy is much higher in European countries and US.
Simone Burns, an Irish lawyer, spat at a flight attendant during her foul-mouthed racist tirade after she was refused alcohol on the flight in November last year.
The Special Investigation Team (SIT) formed by the Punjab Government to probe the Neha Shoree murder case has found the name and number of the killer saved on her phone.
An Indian journal publisher and his companies have been fined over USD 50 million in the US for making “deceptive claims” to academics about the nature of their work and taking millions of dollars from aspiring researchers and writers.
The Bench, also comprising Justices Deepak Gupta and Sanjiv Khanna, has now fixed the contempt petition of the Japanese firms against the former Ranbaxy promoters for hearing on April 11.
